ZERO - The Project to End Prostate Cancer
ABOUT PROSTATE CANCERGET INVOLVEDPROGRAMSRESEARCHPARTNERSSTOREABOUT US
Risk Factors
Prevention
Detection
Diagnosis
Treatment
New Prostate Cancer Research
Prostate Cancer Resources
Managing Bone Metastases and Pain
Side Effects of Prostate Cancer Treatment

Prostate Cancer Testing Is Best Option for Men

Dr. Patrick C. Walsh | QUEST | Winter 2009

Until an alternative exists, prostate cancer testing is the best option we have to allow men to make an informed decision. Disparaging testing does a great disservice. Because prostate cancer produces no symptoms until it's too far advanced to cure, as appropriate, men should have a PSA test and examination.

In 1990, before PSA testing, only 68% of newly diagnosed men had localized cancer and 21% were metastatic.

Today, 91% are diagnosed with localized disease and only 4% have metastases.

With the ability to diagnose cancer earlier and treatment advances, U.S. deaths from prostate cancer have fallen 40% in ten years, a greater decline than for any other cancer.

Today, men have a choice that once did not exist: Undergo testing and, if there is cancer, make an informed choice for treatment or observation, or do nothing and run the risk of a diagnosis until it's too late.

I choose to know.

*Patrick C. Walsh, M.D. is the University Distinguished Service Professor of Urology at the James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions

Copyright QUEST 2009

 

All active news articles
About Prostate Cancer  |  Donate  |  Get Involved  |  Programs  |  Research   |  Partners  |  Store  |  About Us  |  Site Map  |  Contact Us  |  Privacy PolicySubscribe to the ZERO Prostate Cancer News Feed  

© Copyright 2010, ZERO - The Project to End Prostate Cancer. All rights reserved.

ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health
service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles
are the copyrights of the respective owners.